HTG Molecular Diagnostics Inc (NASDAQ:HTGM) shares are trading higher by $6.60 at $10.53 in Friday's session. That comes on top of Thursday's gain of nearly $2.00 as it rallied from $2.14 to $3.93 on monster volume.
After Wednesday's close, the company (a maker of instruments, reagents and services for molecular profiling applications) announced it had obtained CE marking for in the European Union for its HTG EdgeSeq ALKPlus Assay. The diagnostic assay analyzes gene arrangements in patients with lung cancer.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
After Thursday's close, HTG reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
After a much higher open, the stock had a brief retreat to $5.97 before continuing its move higher. So far, the ensuing rally taken the issue to $12.45, but has backed off to the $11.00 area. That marks the highest level for the issue since September 2015, when it peaked at $13.10.